Loading...
Loading...
India's empagliflozin imports from BANGLADESH total $380 across 5 shipments from 2 foreign suppliers. BEXIMCO PHARMACEUTICALS LTD. leads with $364 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include AXIS CLINICALS LIMITED. This corridor reflects India's pharmaceutical import demand for empagliflozin โ a concentrated sourcing relationship with select suppliers from BANGLADESH.

BEXIMCO PHARMACEUTICALS LTD. is the leading Empagliflozin supplier from BANGLADESH to India, with import value of $364 across 2 shipments. The top 5 suppliers โ BEXIMCO PHARMACEUTICALS LTD., M/S. BEXIMCO PHARMACEUTICALS LTD., โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | BEXIMCO PHARMACEUTICALS LTD. | $364 | 2 | 95.8% |
| 2 |
| M/S. BEXIMCO PHARMACEUTICALS LTD., |
| $16 |
| 3 |
| 4.2% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | AXIS CLINICALS LIMITED | $364 | 2 | 95.8% |
| 2 | ARAGEN LIFE SCIENCES LIMITED | $16 | 3 | 4.2% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Empagliflozin suppliers from BANGLADESH to India include BEXIMCO PHARMACEUTICALS LTD., M/S. BEXIMCO PHARMACEUTICALS LTD.,. The leading supplier is BEXIMCO PHARMACEUTICALS LTD. with import value of $364 USD across 2 shipments. India imported Empagliflozin worth $380 USD from BANGLADESH in total across 5 shipments.
India imported Empagliflozin worth $380 USD from BANGLADESH across 5 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Empagliflozin sourced from BANGLADESH include AXIS CLINICALS LIMITED, ARAGEN LIFE SCIENCES LIMITED. The largest buyer is AXIS CLINICALS LIMITED with $364 in imports across 2 shipments.
The total value of Empagliflozin imports from BANGLADESH to India is $380 USD, across 5 shipments and 2 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
5 Verified Shipments
2 suppliers, 2 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists